Literature DB >> 16044021

The effect of statins on HIV rebound and blips.

Laura Waters, Justin Stebbing, Rachael Jones, Sundhiya Mandalia, Mark Bower, Milena Stefanovic, Mark Nelson, Brian Gazzard.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16044021

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

1.  Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.

Authors:  Nicholas T Funderburg; Ying Jiang; Sara M Debanne; Norma Storer; Danielle Labbato; Brian Clagett; Janet Robinson; Michael M Lederman; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2013-11-18       Impact factor: 9.079

2.  High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.

Authors:  Anuradha Ganesan; Nancy Crum-Cianflone; Jeanette Higgins; Jing Qin; Catherine Rehm; Julia Metcalf; Carolyn Brandt; Jean Vita; Catherine F Decker; Peter Sklar; Mary Bavaro; Sybil Tasker; Dean Follmann; Frank Maldarelli
Journal:  J Infect Dis       Date:  2011-02-15       Impact factor: 5.226

3.  Attenuation of immune activation in an open-label clinical trial for HIV-AIDS using a polyherbal formulation.

Authors:  Mangaiarkarasi Asokan; Vijaya Sachidanandam; Kadappa Shivappa Satish; Udaykumar Ranga
Journal:  Virusdisease       Date:  2014-05-21

4.  Current use of statins reduces risk of HIV rebound on suppressive HAART.

Authors:  Henning Drechsler; Colby Ayers; James Cutrell; Naim Maalouf; Pablo Tebas; Roger Bedimo
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

5.  Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial.

Authors:  Carlos J Montoya; Fabian Jaimes; Edwin A Higuita; Sandra Convers-Páez; Santiago Estrada; Francisco Gutierrez; Pedro Amariles; Newar Giraldo; Cristina Peñaloza; Maria T Rugeles
Journal:  Trials       Date:  2009-06-18       Impact factor: 2.279

Review 6.  Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection.

Authors:  Boghuma Titanji; Christina Gavegnano; Priscilla Hsue; Raymond Schinazi; Vincent C Marconi
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.